Replimune (REPL) Current Assets (2018 - 2025)
Replimune has reported Current Assets over the past 8 years, most recently at $280.4 million for Q4 2025.
- Quarterly results put Current Assets at $280.4 million for Q4 2025, down 48.8% from a year ago — trailing twelve months through Dec 2025 was $280.4 million (down 48.8% YoY), and the annual figure for FY2025 was $495.9 million, up 14.35%.
- Current Assets reached $280.4 million in Q4 2025 per REPL's latest filing, down from $333.7 million in the prior quarter.
- Across five years, Current Assets topped out at $624.0 million in Q4 2022 and bottomed at $280.4 million in Q4 2025.
- Median Current Assets over the past 5 years was $454.5 million (2021), compared with a mean of $459.4 million.
- The largest annual shift saw Current Assets skyrocketed 177.62% in 2021 before it tumbled 48.8% in 2025.
- Over 5 years, Current Assets stood at $427.8 million in 2021, then surged by 45.86% to $624.0 million in 2022, then fell by 23.21% to $479.2 million in 2023, then grew by 14.28% to $547.6 million in 2024, then crashed by 48.8% to $280.4 million in 2025.
- Business Quant data shows Current Assets for REPL at $280.4 million in Q4 2025, $333.7 million in Q3 2025, and $413.4 million in Q2 2025.